Advertisement

Canagliflozin

You have accessRestricted Access
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m²
George Bakris, Megumi Oshima, Kenneth W. Mahaffey, Rajiv Agarwal, Christopher P. Cannon, George Capuano, David M. Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J.L. Heerspink, Adeera Levin, Bruce Neal, Richard Oh, Carol Pollock, Norman Rosenthal, David C. Wheeler, Hong Zhang, Bernard Zinman, Meg J. Jardine and Vlado Perkovic

CJASN November 2020, CJN.10140620; DOI: https://doi.org/10.2215/CJN.10140620

Add to Selected Citations
Open Access
How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?
Joshua J. Neumiller and Rita R. Kalyani

CJASN November 2019, 14 (11) 1667-1669; DOI: https://doi.org/10.2215/CJN.05340419

Add to Selected Citations